Detroit, MI (PRWEB) August 12, 2010
Once again the FDA has rejected a much-anticipated anti-obesity drug by saying that the side effects outweigh its ability to help consumers lose weight. In light of the disappointing performance of the current generation of anti-obesity drugs, it is important for consumers to know that recently relabeled Mirafit fbcx® is a safe and effective alternative. Furthermore, that the results of a double blind placebo controlled cross-over study that was just completed at the UC-Davis Medical Center have demonstrated significant weight loss for volunteers during the active phase of the study; without changes to the volunteers’ diet or exercise regimes. These data are consistent with an earlier study conducted on obese type 2 diabetics and unlike all other studies where all participants are forced onto a low calorie diet as part of a weight loss program. Drs. K-L Catherine Jen and Joseph Artiss, are the inventors of Mirafit and principals in ArtJen Complexus USA, LLC, the company that they formed to manufacture and market this naturally occurring supplement.¬
According to Drs. Jen and Artiss, “Mirafit fbcx is a soluble fiber derived from corn that reduces human body absorption of consumed fat. Taken as directed, six tablets a day, 2 per fat-containing meal, will reduce caloric absorption by 500 calories/day. This is equivalent to approximately 50–60 percent of the fat or 25-30 percent of calories from the typical Western diet. Five hundred kilocalories per day equates to a weight loss of about 1-1 ½ pounds per week.”
How it Works
Unlike the new generation of pharmaceuticals that are designed to alter brain function, Mirafit fbcx is a naturally occurring, soluble fiber that forms a very stable complex with dietary fat in the stomach. As Mirafit is not absorbed into the blood stream it has no effect on brain chemistry. Fat that is bound into a complex with Mirafit is not available for absorption into the blood stream. As the fat remains bound while passing through the large bowel there are no unwanted intestinal side effects.
“Mirafit fbcx binds and eliminates nine times its own weight in dietary fat. One gram (one tablet) of Mirafit binds 9 grams (81 calories) of fat, thus preventing absorption of a significant portion of fat consumed,” said Dr. Jen.
The recently completed clinical study involved overweight, but not obese non-diabetic volunteers. This investigation was intended to confirm the beneficial effects of Mirafit fbcx on weight loss and blood lipid levels as they have been implicated in the development of numerous disease states, including type 2 diabetes and cardiovascular disease.
Data showed that significantly more weight was lost during the active phase as compared to the control phase of the study in the absence of any change to diet or exercise programs. Blood cholesterol, LDL (bad) cholesterol, and the proatherogenic Apolipoprotein B levels were significantly reduced in the active phase while HDL (good) cholesterol levels remained unchanged. Participants with high triglyceride levels reduced their blood cholesterol levels more than twice as much relative to participants with normal triglyceride levels. In addition, the higher the cholesterol levels, the greater the cholesterol reduction in the active phase. Blood insulin levels were reduced in the active phase as compared to those in the control phase, which suggests a reduced risk of developing type 2 diabetes. Unlike any other studied weight loss product, the participants were not put on a low fat or low calorie diet. These data were consistent with an earlier study conducted on obese patients with type 2 diabetes.
“These results indicate that Mirafit fbcx not only exerts its beneficial health effects in obese individuals with type 2 diabetes, but also is effective in improving the blood lipid profile of apparently healthy non-obese individuals,” said Dr. Artiss. “These findings build on previous animal and clinical studies that have demonstrated very positive effects on body weight and blood lipid levels.”
Mirafit fbcx is a soluble dietary fiber that is not absorbed into the blood. The active ingredient in Mirafit fbcx, alpha-cyclodextrin, has been designated by the FDA as Generally Recognized As Safe (GRAS). The World Health Organization has given it an allowable daily intake of “not specified,” suggesting that there is no unsafe level.
About ArtJen Complexus USA, LLC
Mirafit fbcx was developed by Dr. Joseph Artiss, associate professor of Pathology in Wayne State University’s (WSU) School of Medicine (Detroit) and Dr. K-L Catherine Jen, chair of Nutrition and Food Science in WSU’s College of Liberal Arts and Sciences. Artiss and Jen formed ArtJen to commercialize the Mirafit fbcx technology. They acquired the rights to the technology from WSU to bring the product to the worldwide market. To learn more about Mirafit fbcx and its benefits, visit http://www.mirafit.com.